Healthy volunteers test new ADHD pill versions in drug absorption study
NCT ID NCT07253441
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study tested different versions of a drug called centanafadine, which is being developed for ADHD. 174 healthy adults took the drug in various capsule and tablet forms to see how well the body absorbs each version and whether food changes absorption. The goal was to compare the new capsules to the older tablets, not to treat ADHD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Lenexa
Lenexa, Kansas, 66219, United States
-
ICON Salt Lake City
Millcreek, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.